Results of Multiple Biliary Ducts Anastomosis in Living Donor Liver Transplantation-Juniper publishers
JUNIPER PUBLISHERS- OPEN ACCESS JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Abstract
The incidence of Gastro-Esophageal Reflux Disease in
the population of industrialized countries is high and ranges from 20 t!
o 40% in the age groups between 45-64 years with a further increase in
the incidence in the age between 64- 74. The natural history of the
disease requires continuous recrudescence alternated with quiescent
phases. In view of these epidemiological data it is clear the importance
of the social problem and the high health costs. It follows the
interest of Pharmaceutical Companies the Companies of Electromedical and
producing toolkits endoscopic and surgical Companies. In this article I
intend to make a brief stock of the situation about the
gastro-esophageal reflux disease. I will make a tour of the clinical
presentation the increase of incidence especially of so-called atypical
forms and symptoms of gastro-pharingeal reflux (high reflux) emphasizing
how many patients are refractory to therapy. Patients who benefit from
medical treatment they become dependent on care. Whereas many are young
and that medical therapy has adverse side effects such as anemia
osteoporosis and infections is the need for alternative therapies.
Physiotherapy global posture for example can be a transient and partial
support. The ultimate solution is or should be surgical. Surgical
therapy makes use of minimally invasive or laparoscopic method which
shortens the hospital stay. But an endoscopic surgery easy repeatable
free from postoperative complications can be performed in day surgery
would be ideal for this type of chronic disease. In reviewing the
different techniques that have been proposed over the last twenty years I
relate the considerations derived from the international literature.
Conclude by presenting a last device manufactured in Germany derived
from its precursor the NDO Plicator which making use of the addition of
heads polytetrafluoroethylene (PTFE) which retain the suture threads
from the traction exerted by the tissues seem to improve the seal in
time. I make a brief summary of the main endoscopic therapies for the
disease by reflusso.Io believe that there is room for this type of
therapeutic approach which is a step before surgery.
Epidemiology and Clinical Presentation
The incidence of reflux disease or Gastro-Esophageal
reflux disease or Gastro-Laryngeal reflux disease reaches up to over 50%
of the general population. The natural history of the disease includes
periods of wellness alternating with periods of exacerbation. The flat
mucosa of the esophagus is not designed to withstand the irritating
contents which come from the stomach. The regurgitation from the stomach
therefore create disorder with or without tissue damage associated.
Gastric reflux irritates the esophagus and larynx.
The symptoms are caused by the refluxed acid or alkali or mixed which
comes from the stomach and the duodenum. Often there is no match between
the symptoms and organ damage documented: this is called N.E.R.D. (Not
Esophagitis Reflus Disease). The quality of life is highly invalidated
and gastroscopy shows an almost normal finding. Incontinence of the
cardia
which is documented causes serious trouble. The organ
damage can be erosions and ulcers and there is the possibility of an
inflamed tissue transformation in metaplastic sense (BARGHett’s
esophagus) and dysplastic. This is a precancerous lesion. More
frequently the continuous recurrence of reflux does not cause organ
damage but causes a major inconvenience.
The clinical presentation is manifested by typical
symptoms of heartburn and regurgitation or with cardiac neurological
symptoms ENT and pneumological such as palpitations chest pain headache
cough laryngitis the burning mouth otitis the bronchopathies a sense of
suffocation even in the absence of the classic heartburn.
Treatment
The advent of Proton Pump Inhibitors has modified the
therapeutic trends whereas these drugs in many cases are decisive. But
the protracted and indiscriminate use of these
medicines can bring negative consequences for health. The latest
research grant the proton pump inhibitors major side effects
of which it was given less importance in the past. They would
promote intestinal and broncho-pulmonary infection because
they reduce the acid bARGHier. They can cause hypochromic anemia
reduced absorption of folate and iron. Reduce the serum calcium
and the magnesiemia and this promotes the catabolic processes
of the bone and consequently the pathological fractures.
Non-drug therapies
In clinical practice occurs less effectiveness of these products
not because they give habituation over time but because the
clinical presentation of the disease is often complex and is
manifested as a motor disorder with visceral hyperalgesia and
sphincter apparatus malfunction. The “alternative” treatments
which sometimes advise my patients have increasingly spread
for the possibility of reducing significantly taking the drugs. The
global postural type physiotherapy for example which acts on
the diaphragm and on the apparatus of cardia sphincter obtains
in cases studied and selected a good effect. Pharmacological
treatments have adapted preferring at times psychoactive
drugs which act on the enteric nervous system and motility.
But often the same patients complain of dependence from
taking daily medication and seek a permanent solution and not
pharmacological.
Consequence of this is the return to a “traditional” remedy
shelved since the advent of PPI. Today the surgery can be
performed laparoscopically and this has changed the instructions
to run it. Some technological innovations like the magnetic collar
Lynx increase the ability to choose the type of intervention.
The collar is placed around the esophagus with a laparoscopic
surgery without altering the structure of the apparatus
esophageal-gastric sphincter. Studies are underway to test the
effectiveness of this procedure. New impetus have the surgery
Endoscopic techniques which reinforce the esophageal-gastric
sphincter apparatus with endoluminal fundoplication that is
performed with a gastroscopy without resorting to surgery.
Both the choice the Endoscopic and tha Surgical one require a
prior anatomical and pathophysiological study of the stomach
and esophagus. After clinical assessment and gastroscopy for
anatomical study you should run the ph- Impedenzio metry
of 24 hours and esophageal manometry. These last two tests
document the degree of cardia incontinence and demonstrate
the correlation between disorders and episodes of reflux.
Endoscopic therapy
In recent years many endoscopic methods have been
developed for a conservative treatment aimed at patients
not respoder to medical therapy and in patients for whom it
was preferable to a non-pharmacological treatment. These
procedures are simple economical and repeatable. They include technical of intraluminal suture the radio-ablation (STRETTA
procedure) and injection of inert substances not absorbable.
STRETTA procedure is to put some needle electrodes in the distal
esophagus applying of these radio frequency energy burning
mucosa it creates a reactive fibrosis and makes it insensitive
to algogenic stimuli. This method is used mainly for treating’
“BARGHett’s esophagus” because it burns the tissue and eliminates
the diseased mucosa.
The endoscopic injection of “bulking agents” was used in the
past and is still performed in some American countries. It has
discrete effects in controlling symptoms in the short and medium
term improving the manometric findings. Many substances have
been used: bovine collagen polietilenmetacrilato (Plexiglas) the
ethylene-vinyl alcohol polymer (Enterix) but some have been
withdrawn from the market due to adverse events. The injection
of foreign material can cause inflammation and ischemia of the
esophageal mucosa. They have also been described remotely
reactions such as embolization in the case of Enteryx which was
removed from the market for theintervention of the Food and
Drug Administration.
Endoscopic techniques
Endoscopic procedures currently used are those defined
“endoluminal Gastro Plication (ELGP)” which include the
Esophyx the MUSE method the EndoCinch and GERD-X [1]. They
enable the cARGHying out of the fundoplication during Gastroscopy
identical to the surgical. These endoscopic techniques are
possible in selected cases when the gastric hiatal hernia is not
greater than 20 mm and it has been established the correlation
between symptoms and reflux.
Esophyx
The Esophyx device creates a fundoplication suturing the
mucous tissue in several places. The operation is performed
under vision of a flexible endoscope and there is the need to
work with double instrument.
Muse
Another endoscopic technique Transoral Incisionless
Fundoplication (TIF) is that defined MUSE Medigus Ultrasonic
Surgical Endostapler which is done with an instrument equipped
with a mini-ultrasound as well as a stapler. It performs a partial
anterior fundoplication. It is equipped with a camera of the
ultrasound probe and a rangefinder. The instrument includes
a handle with the controls a flexible and a rigid section axis
containing a cartridge with five surgical clips.
EndoCinch
The pecularity of this method is to capture in a niche located
near the tip of the endoscope the mucosa of the upper stomach
which you want to attach to the mucosa of the sphincter cardia
to form the fundoplication. This mucosa is sutured to form folds
and reduce cardia space.
The EndoCinch system must be operated with two
instruments and over-tube. The room where it is sucked the
mucosa of the esophagogastric junction enables suturing the
tissue in a situation of stability but despite this the long-term
sealing of the method is not effective.
Results
The initial results of these three methods have been
encouraging but long-term studies have verified the recurrence
of symptoms for the failure of the sutures. With endoscopic
surgery it is unable to mobilize the gastric fundus as in
traditional surgery to apply more resistant to traction sutures.
In the long run the traction force exerted on the sutures causes
the esophagogastric junction again become incontinent. Even
surgical procedures are beset by varying percentages of relapses
sometimes after a short period. But of course the endoscopic
techniquespresent with greater frequency this problem in the
face of greater ease of execution of lower costs and ease to again
perform the intervention.
GERD-X
The newer endoscopic technique GERD-X which takes its
name from stappler endoscopic used seems to promisesolution
to poor sealing in the time. This “device” has the advantage
of having at the end of the suture applied two small plates
polyurethane which make the suture more solid and stable over
time. The success of the intervention is comparable according to
recent studies cARGHied out in Germany and Austria to traditional
surgery Nissen fundoplication or Toupet. The follow-up in
progress are showing that the problem of the shorter duration
compared to surgery is passed from the addition of these
platelets [2].
For a chronic condition as is that of the gastro-oesophageal
reflux the ideal is a simple cheap surgery efficient and repeatable.
Endoscopic fundoplication (one that is made by gastroscopy) has
obvious advantages compared to surgery is about the length of
stay the execution costs and the ability to repeat the procedure.
Basically you can reduce the hiatus hernia and incontinence of
the cardia with a gastroscopy.
Why prefer the endoscopic surgery?
The surgery presents a higher percentage of risk compared
to the gastroscopy the most frequent of which is the esophageal
stenosis post-operative. Not to mention the possibility of bleeding and perforations. You need a hospital stay of 4-5 days
and it is not always possible to repeat the operation in case of
failure or relapse. Endoscopy with GERD-X method involves an
intervention in Day Hospital stapler with a single-use which
is introduced during the gastroscopy whose advantage over
generational precursors is to have a greater hold over time thanks
to two small plates polyurethane formed from the material used
for the hernia networks which make the suture applied more
solid and stable.
This device is the evolution of the NDO Plicator produced
by a company of electromedical Massachusetts acquired
in 2008 by Johnson & Johnson which ceased production of
Plicator. The Plicator the NDO Company also had the heads in
polytetrafluoroethylene (PTFE) which allow a greater tightness
of the suture. The case studies of work of the NDO Plicator has
shown good efficacy of these endoluminal suturing in some
previous studies in 2008. The Plicator NDO was a mechanical
device and reusable while the GERDX has the advantage of a
hydraulic mechanism which does not include blocks and is
disposable free from bacterial contamination problems. The
risks of this endoscopic procedure are practically zero and in any
case absolutely lower compared to those surgical [3].
I refer to the corresponding sections of my professional sites
www.iannetti.it,
www.gastroenterologoiannetti.com and those who want to
know more both about the clinical presentation of reflux disease
both regarding diagnostic methods medical therapy with proton
pump inhibitors and endoscopic and laparoscopic surgical
therapies.
For more Open Access Journals in Juniper
Publishers please click
on: https://juniperpublishers.com
For more articles in Advanced Research in
Gastroenterology & Hepatology Journal click on:
https://juniperpublishers.com/argh/index.php
https://juniperpublishers.com/argh/index.php
For more Open Access Journals please click on: https://juniperpublishers.com
Comments
Post a Comment